Sultopride

DB13273ApprovedSmall molecule

Sultopride is used in Japan, Hong Kong, and Europe to treat schizophrenia. It is of the drug class atypical antipsychotics .

Chemical structure of Sultopride
Mechanism
Curator reviewed
Formula / weight
C17H26N2O4S · 354.47 g/mol (avg)
Code names
LIN 1418

Resolves to

Compound
UNIIAA0G3TW31WCAS53583-79-2ChEMBLCHEMBL277945ChEBI9356KEGGC11708
Clinical / RWD
RxNorm37416ATCN05AL02
Structure
InChIKeyUNRHXEPDKXPRTM-UHFFFAOYSA-NSMILESCCN1CCCC1CNC(=O)C1=CC(=CC=C1OC)S(=O)(=O)CC
Targets
P14416DRD2Q12809KCNH2

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,023Drug interactionsStructured to mechanism, not free text
Sign in
3Marketed productsAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 20 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Sultopride, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In